Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO1M
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -2.1 %
2W -1.3 %
1M 1.1 %
3M -5.5 %
6M 0.9 %
9M -6.2 %
1Y -2.5 %
Alpha
-16.9%
Beta
0.72
sharpe-R
-0.02
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:00:57
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -17.02%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.45% -9.54%
The percentage of cash held in the portfolio is: 92.55%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.45% -9.54%
The percentage of cash held in the portfolio is: 92.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 0.36%
ORGO Sell All 11.11%
Assets Rebalanced
None
2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 10.07% 3.36%
ORGO Organogenesis Holdings Inc. Buy 10.01% 10.51%
RGNX REGENXBIO Inc. Buy 7.45% -9.29%
The percentage of cash held in the portfolio is: 72.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All -12%
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 8.51% -13.2%
MD Pediatrix Medical Group, Inc. Buy 9.97% 1.79%
ORGO Organogenesis Holdings Inc. Buy 10% 9.91%
RGNX REGENXBIO Inc. Buy 7.36% -10.78%
The percentage of cash held in the portfolio is: 64.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All -2.52%
Assets Rebalanced
None
2025-02-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 9.4% -2.9%
ACRS Aclaris Therapeutics, Inc. Buy 9.27% -4.4%
MD Pediatrix Medical Group, Inc. Buy 9.67% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.65% 7.21%
RGNX REGENXBIO Inc. Buy 7.98% -2.23%
The percentage of cash held in the portfolio is: 54.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All -15.67%
INSM Sell All 13.33%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 9.41% -1.59%
INSM Insmed Incorporated Buy 11.1% 15.99%
ACRS Aclaris Therapeutics, Inc. Buy 9.54% -0.4%
MD Pediatrix Medical Group, Inc. Buy 9.32% -2.64%
ORGO Organogenesis Holdings Inc. Buy 9.24% 3.9%
AGEN Agenus Inc. Buy 8.24% -8.62%
RGNX REGENXBIO Inc. Buy 8.2% 1.73%
The percentage of cash held in the portfolio is: 34.95%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Sell All 1.06%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.73% 4.86%
AXGN AxoGen, Inc. Buy 9.6% 3.45%
INSM Insmed Incorporated Buy 10.96% 18.15%
ACRS Aclaris Therapeutics, Inc. Buy 9.55% 2.8%
MD Pediatrix Medical Group, Inc. Buy 9.27% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.32% 8.11%
AGEN Agenus Inc. Buy 8.9% 1.83%
RGNX REGENXBIO Inc. Buy 8.16% 4.46%
The percentage of cash held in the portfolio is: 24.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 71.66%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.95% 1.19%
AXGN AxoGen, Inc. Buy 9.66% -1.81%
INSM Insmed Incorporated Buy 11.11% 12.98%
NUTX Nutex Health Inc. Buy 15.09% 53.16%
ACRS Aclaris Therapeutics, Inc. Buy 9.46% -4%
MD Pediatrix Medical Group, Inc. Buy 9.78% -0.57%
ORGO Organogenesis Holdings Inc. Buy 9.36% 2.4%
AGEN Agenus Inc. Buy 8.49% -8.36%
RGNX REGENXBIO Inc. Buy 8.03% -3.1%
The percentage of cash held in the portfolio is: 9.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.88% 2.41%
AXGN AxoGen, Inc. Buy 9.62% -0.22%
INSM Insmed Incorporated Buy 10.71% 11.1%
NUTX Nutex Health Inc. Buy 14.38% 48.84%
ACRS Aclaris Therapeutics, Inc. Buy 9.58% -0.8%
MD Pediatrix Medical Group, Inc. Buy 9.63% -0.14%
ORGO Organogenesis Holdings Inc. Buy 9.91% 10.51%
AGEN Agenus Inc. Buy 9.02% -0.78%
SIGA SIGA Technologies, Inc. Buy 7.14% -6.42%
RGNX REGENXBIO Inc. Buy 8.13% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGNX
Assets Removed
Asset Action Perf %
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.95% 1.36%
AXGN AxoGen, Inc. Buy 9.64% -1.75%
INSM Insmed Incorporated Buy 11.05% 12.62%
NUTX Nutex Health Inc. Buy 12.43% 26.44%
ACRS Aclaris Therapeutics, Inc. Buy 9.63% -2%
MD Pediatrix Medical Group, Inc. Buy 10.29% 4.86%
ORGO Organogenesis Holdings Inc. Buy 10.24% 12.31%
AGEN Agenus Inc. Buy 8.69% -6.01%
SIGA SIGA Technologies, Inc. Buy 7.71% -0.78%
TGTX TG Therapeutics, Inc. Buy 8.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 9.94% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 9.18% -5.98%
AXGN AxoGen, Inc. Buy 10.1% 3.51%
INSM Insmed Incorporated Buy 11.11% 13.81%
NUTX Nutex Health Inc. Buy 11.64% 19.09%
ACRS Aclaris Therapeutics, Inc. Buy 10.17% 4%
MD Pediatrix Medical Group, Inc. Buy 9.81% 0.5%
ORGO Organogenesis Holdings Inc. Buy 9.53% 5.11%
AGEN Agenus Inc. Buy 8.79% -4.44%
SIGA SIGA Technologies, Inc. Buy 7.73% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 7.95% -17.94%
AORT Artivion, Inc. Buy 10.13% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 8.91% -8.12%
AXGN AxoGen, Inc. Buy 10.07% 3.95%
INSM Insmed Incorporated Buy 10.79% 11.34%
NUTX Nutex Health Inc. Buy 11.68% 20.31%
ACRS Aclaris Therapeutics, Inc. Buy 10.09% 4%
MD Pediatrix Medical Group, Inc. Buy 9.69% 0%
ORGO Organogenesis Holdings Inc. Buy 9.55% 6.01%
AGEN Agenus Inc. Buy 9.13% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AGEN
Assets Removed
Asset Action Perf %
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.84% 0.47%
BLUE bluebird bio, Inc. Buy 8.15% -16.73%
AORT Artivion, Inc. Buy 10.12% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 9.46% -3.42%
AXGN AxoGen, Inc. Buy 9.89% 0.99%
INSM Insmed Incorporated Buy 10.34% 5.54%
NUTX Nutex Health Inc. Buy 11.61% 18.31%
ACRS Aclaris Therapeutics, Inc. Buy 9.85% 0.4%
MD Pediatrix Medical Group, Inc. Buy 9.64% -1.64%
ORGO Organogenesis Holdings Inc. Buy 9.1% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ORGO
Assets Removed
Asset Action Perf %
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.65% -3.76%
BLUE bluebird bio, Inc. Buy 8.38% -16.43%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.58% -4.51%
AORT Artivion, Inc. Buy 9.98% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 9.48% -5.56%
AXGN AxoGen, Inc. Buy 10.3% 2.63%
INSM Insmed Incorporated Buy 10.22% 1.84%
NUTX Nutex Health Inc. Buy 10.27% 2.16%
ACRS Aclaris Therapeutics, Inc. Buy 10.09% 0.4%
MD Pediatrix Medical Group, Inc. Buy 10.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.69% -4.19%
BLUE bluebird bio, Inc. Buy 8.17% -19.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.44% -6.67%
AORT Artivion, Inc. Buy 9.94% -1.82%
ARDX Ardelyx, Inc. Buy 10.65% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 9.69% -4.27%
AXGN AxoGen, Inc. Buy 10.11% -0.05%
INSM Insmed Incorporated Buy 10.03% -0.93%
NUTX Nutex Health Inc. Buy 10.14% 0%
ACRS Aclaris Therapeutics, Inc. Buy 10.14% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.65% -3.07%
BLUE bluebird bio, Inc. Buy 8.52% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.7% -2.56%
AORT Artivion, Inc. Buy 9.66% -2.94%
ARDX Ardelyx, Inc. Buy 10.96% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 9.7% -2.56%
AXGN AxoGen, Inc. Buy 9.95% 0%
INSM Insmed Incorporated Buy 9.95% 0%
The percentage of cash held in the portfolio is: 21.91%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.7% -3.63%
BLUE bluebird bio, Inc. Buy 8.59% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.82% -2.46%
AORT Artivion, Inc. Buy 9.95% -1.16%
ARDX Ardelyx, Inc. Buy 9.56% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 10.08% 0%
The percentage of cash held in the portfolio is: 42.3%
New Assets Added
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10% 0.36%
BLUE bluebird bio, Inc. Buy 8.5% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.72% -2.46%
AORT Artivion, Inc. Buy 9.97% 0%
ARDX Ardelyx, Inc. Buy 9.97% 0%
The percentage of cash held in the portfolio is: 51.84%
New Assets Added
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.82% -0.82%
BLUE bluebird bio, Inc. Buy 9% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 71.29%
New Assets Added
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
BLUE bluebird bio, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2025-01-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All -3.61%
Assets Rebalanced
None
2024-12-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 10.89% 3.77%
The percentage of cash held in the portfolio is: 89.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 1%
MGNX Sell All -4.12%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.68% 4.2%
MGNX MacroGenics, Inc. Buy 10.28% 0.29%
PCRX Pacira BioSciences, Inc. Buy 11.06% 6.5%
The percentage of cash held in the portfolio is: 67.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.61% 7.32%
MGNX MacroGenics, Inc. Buy 10.12% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 12.5% 23.55%
PCRX Pacira BioSciences, Inc. Buy 10.01% 0%
The percentage of cash held in the portfolio is: 56.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Sell All 1.13%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.35% 2.73%
APLS Apellis Pharmaceuticals, Inc. Buy 10.13% 4.6%
MGNX MacroGenics, Inc. Buy 9.94% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 11.7% 18.06%
RVNC Revance Therapeutics, Inc. Buy 9.81% 0%
PCRX Pacira BioSciences, Inc. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 41.25%
New Assets Added
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.23% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 10.47% 8.55%
MGNX MacroGenics, Inc. Buy 10.47% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.58% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 51.37%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 51.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 7.41% -1.39%
ITGR Integer Holdings Corporation Buy 7.32% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 10.07% 4.63%
MGNX MacroGenics, Inc. Buy 10.31% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.48% 0%
FATE Fate Therapeutics, Inc. Buy 10.48% 0%
The percentage of cash held in the portfolio is: 43.92%
New Assets Added
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
HCSG Sell All 13.06%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.69% 10.78%
NEOG Neogen Corporation Buy 7.54% -1.19%
ITGR Integer Holdings Corporation Buy 7.33% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 9.78% 0%
MGNX MacroGenics, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 50.88%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.17% 6.67%
NEOG Neogen Corporation Buy 7.98% 4.46%
ITGR Integer Holdings Corporation Buy 7.31% 0.99%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 18.73%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.43% 17.66%
HCSG Healthcare Services Group, Inc. Buy 13.87% 3.74%
NEOG Neogen Corporation Buy 8.09% 5.23%
ITGR Integer Holdings Corporation Buy 7.11% -2.37%
The percentage of cash held in the portfolio is: 61.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.36% 17.18%
HCSG Healthcare Services Group, Inc. Buy 14.05% 5.39%
NEOG Neogen Corporation Buy 7.8% 1.81%
MGNX MacroGenics, Inc. Buy 8.11% -7.75%
ITGR Integer Holdings Corporation Buy 7.07% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.33% -5.24%
The percentage of cash held in the portfolio is: 42.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.64% 12.89%
CDMO Avid Bioservices, Inc. Buy 9% 15.15%
HCSG Healthcare Services Group, Inc. Buy 14.2% 8.95%
NEOG Neogen Corporation Buy 7.65% 2.09%
MGNX MacroGenics, Inc. Buy 8.46% -1.55%
ITGR Integer Holdings Corporation Buy 7% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.24% -3.91%
RGEN Repligen Corporation Buy 9.23% -5.34%
The percentage of cash held in the portfolio is: 23.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.47% 15.04%
NUTX Nutex Health Inc. Buy 11.38% 31.39%
CDMO Avid Bioservices, Inc. Buy 8.88% 17.76%
HCSG Healthcare Services Group, Inc. Buy 14% 11.32%
NEOG Neogen Corporation Buy 7.65% 5.86%
MGNX MacroGenics, Inc. Buy 8.08% -2.58%
ITGR Integer Holdings Corporation Buy 6.89% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.18% -0.89%
ALT Altimmune, Inc. Buy 11.07% 0.32%
RGEN Repligen Corporation Buy 9.41% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.03% 11.11%
VREX Varex Imaging Corporation Buy 9.46% 18.26%
NUTX Nutex Health Inc. Buy 12.74% 51.33%
CDMO Avid Bioservices, Inc. Buy 8.64% 18.05%
HCSG Healthcare Services Group, Inc. Buy 13.88% 13.61%
NEOG Neogen Corporation Buy 7.51% 6.97%
MGNX MacroGenics, Inc. Buy 8.53% 5.94%
ITGR Integer Holdings Corporation Buy 6.66% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.83% -1.24%
ALT Altimmune, Inc. Buy 10.72% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.29% 13.48%
VREX Varex Imaging Corporation Buy 9.73% 20.74%
NUTX Nutex Health Inc. Buy 9.53% 12.45%
CDMO Avid Bioservices, Inc. Buy 8.72% 18.24%
HCSG Healthcare Services Group, Inc. Buy 13.71% 11.51%
IOVA Iovance Biotherapeutics, Inc. Buy 11.87% -3.45%
NEOG Neogen Corporation Buy 8.09% 14.37%
MGNX MacroGenics, Inc. Buy 9.2% 13.44%
ITGR Integer Holdings Corporation Buy 6.83% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.29% 13.07%
VCEL Vericel Corporation Buy 10.54% 28.3%
VREX Varex Imaging Corporation Buy 9.5% 17.52%
NUTX Nutex Health Inc. Buy 10.81% 27.16%
CDMO Avid Bioservices, Inc. Buy 8.75% 18.34%
HCSG Healthcare Services Group, Inc. Buy 13.38% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 11.85% -3.99%
NEOG Neogen Corporation Buy 8.03% 13.18%
MGNX MacroGenics, Inc. Buy 9.14% 12.4%
ITGR Integer Holdings Corporation Buy 6.72% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ITGR
Assets Removed
Asset Action Perf %
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.08% 0.83%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.07% 0.67%
VCEL Vericel Corporation Buy 9.41% 4.51%
VREX Varex Imaging Corporation Buy 9.67% 9.09%
NUTX Nutex Health Inc. Buy 8.49% -8.94%
CDMO Avid Bioservices, Inc. Buy 8.04% -0.87%
HCSG Healthcare Services Group, Inc. Buy 13.78% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 13.72% 1.45%
NEOG Neogen Corporation Buy 7.83% 0.7%
MGNX MacroGenics, Inc. Buy 8.92% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.07% -0.23%
ARDX Ardelyx, Inc. Buy 8.98% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.31% 3.2%
VCEL Vericel Corporation Buy 9.83% 8.89%
VREX Varex Imaging Corporation Buy 9.77% 10%
NUTX Nutex Health Inc. Buy 8.32% -10.96%
CDMO Avid Bioservices, Inc. Buy 7.99% -1.74%
HCSG Healthcare Services Group, Inc. Buy 13.65% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 13.29% -1.99%
NEOG Neogen Corporation Buy 7.8% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.78% -2.58%
ARDX Ardelyx, Inc. Buy 8.73% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.32% 4.24%
VCEL Vericel Corporation Buy 9.7% 8.48%
VREX Varex Imaging Corporation Buy 9.56% 8.68%
NKTR Nektar Therapeutics Buy 8.25% -6.21%
NUTX Nutex Health Inc. Buy 8.95% -3.3%
CDMO Avid Bioservices, Inc. Buy 7.85% -2.51%
HCSG Healthcare Services Group, Inc. Buy 13.43% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 13.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.95% -7.04%
ARDX Ardelyx, Inc. Buy 9.13% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.92% 3.82%
VCEL Vericel Corporation Buy 9.93% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 14.76% 54.64%
VREX Varex Imaging Corporation Buy 10.03% 6.69%
NKTR Nektar Therapeutics Buy 8.56% -8.97%
NUTX Nutex Health Inc. Buy 9.68% -2.14%
CDMO Avid Bioservices, Inc. Buy 8.3% -3.47%
The percentage of cash held in the portfolio is: 10.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 8.95% -6.57%
ORGO Organogenesis Holdings Inc. Buy 8.99% -6.17%
ARDX Ardelyx, Inc. Buy 8.78% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.78% 2.89%
VCEL Vericel Corporation Buy 9.55% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 15.08% 58.76%
VREX Varex Imaging Corporation Buy 9.86% 5.37%
NKTR Nektar Therapeutics Buy 9.09% -2.76%
NUTX Nutex Health Inc. Buy 9.36% -4.88%
CDMO Avid Bioservices, Inc. Buy 8.56% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.24% -4.23%
ORGO Organogenesis Holdings Inc. Buy 9.71% 0.65%
ARDX Ardelyx, Inc. Buy 9.16% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.08% 5.27%
VCEL Vericel Corporation Buy 9.52% -0.62%
CDXS Codexis, Inc. Buy 9.32% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 11.94% 24.74%
VREX Varex Imaging Corporation Buy 9.76% 3.64%
NKTR Nektar Therapeutics Buy 9.36% -0.69%
NUTX Nutex Health Inc. Buy 9.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
None
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.77% -1.64%
ORGO Organogenesis Holdings Inc. Buy 10.03% 0.97%
ARDX Ardelyx, Inc. Buy 9.6% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.44% 5.84%
VCEL Vericel Corporation Buy 9.65% -2.16%
CDXS Codexis, Inc. Buy 9.57% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 9.25% -6.19%
VREX Varex Imaging Corporation Buy 10.11% 4.13%
NKTR Nektar Therapeutics Buy 9.3% -4.14%
The percentage of cash held in the portfolio is: 12.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.2% 4.23%
ORGO Organogenesis Holdings Inc. Buy 9.76% -0.32%
ARDX Ardelyx, Inc. Buy 9.38% -3.48%
BKD Brookdale Senior Living Inc. Buy 10.62% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.46% 7.64%
VCEL Vericel Corporation Buy 9.39% -3.37%
CDXS Codexis, Inc. Buy 9.65% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.41% -3.09%
VREX Varex Imaging Corporation Buy 9.56% 0%
NKTR Nektar Therapeutics Buy 9.56% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.07% 3.05%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.9%
ARDX Ardelyx, Inc. Buy 9.59% -1.16%
BKD Brookdale Senior Living Inc. Buy 9.73% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.96% 2.69%
VCEL Vericel Corporation Buy 9.67% -0.33%
RDNT RadNet, Inc. Buy 9.72% 0.2%
CDXS Codexis, Inc. Buy 9.7% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 0%
The percentage of cash held in the portfolio is: 11.7%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.93% 0.7%
ORGO Organogenesis Holdings Inc. Buy 9.89% 0.32%
ARDX Ardelyx, Inc. Buy 9.7% -0.83%
BKD Brookdale Senior Living Inc. Buy 9.78% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.78% 0%
VCEL Vericel Corporation Buy 9.78% 0%
RDNT RadNet, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 31.35%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.86% 0%
ORGO Organogenesis Holdings Inc. Buy 9.83% -0.32%
ARDX Ardelyx, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.52%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.77% -1.17%
ORGO Organogenesis Holdings Inc. Buy 9.7% -1.95%
The percentage of cash held in the portfolio is: 80.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.88% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.79% 0%
ORGO Organogenesis Holdings Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 12.46% 16.82%
The percentage of cash held in the portfolio is: 87.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.61% 8%
PODD Insulet Corporation Buy 12.45% 16.92%
NVCR NovoCure Limited Buy 8.26% -8.98%
The percentage of cash held in the portfolio is: 68.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.69% 9.14%
PODD Insulet Corporation Buy 12.41% 16.9%
NVCR NovoCure Limited Buy 8.29% -8.42%
MYGN Myriad Genetics, Inc. Buy 8.56% -0.15%
The percentage of cash held in the portfolio is: 60.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.7% 10.29%
PODD Insulet Corporation Buy 12.17% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 8.49% -8.2%
NVCR NovoCure Limited Buy 8.67% -3.32%
MYGN Myriad Genetics, Inc. Buy 8.7% 2.48%
The percentage of cash held in the portfolio is: 51.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.73% 11.15%
AADI Aadi Bioscience, Inc. Buy 10.35% 7.43%
PODD Insulet Corporation Buy 11.95% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.83% -3.83%
NVCR NovoCure Limited Buy 8.86% -0.5%
MYGN Myriad Genetics, Inc. Buy 8.72% 3.45%
The percentage of cash held in the portfolio is: 40.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.85% -1.69%
AGEN Agenus Inc. Buy 10% -0.18%
AADI Aadi Bioscience, Inc. Buy 10.17% 1.71%
PODD Insulet Corporation Buy 12% 10.8%
TVTX Travere Therapeutics, Inc. Buy 12.74% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 9.01% -5.46%
NVCR NovoCure Limited Buy 8.65% -6.37%
MYGN Myriad Genetics, Inc. Buy 8.77% 0.26%
The percentage of cash held in the portfolio is: 18.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.04% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.06% -9.62%
AGEN Agenus Inc. Buy 9.4% -6.22%
AADI Aadi Bioscience, Inc. Buy 10.34% 3.43%
PODD Insulet Corporation Buy 11.62% 7.2%
TVTX Travere Therapeutics, Inc. Buy 12.77% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 8.85% -7.1%
NVCR NovoCure Limited Buy 8.5% -7.98%
MYGN Myriad Genetics, Inc. Buy 8.81% 0.63%
The percentage of cash held in the portfolio is: 10.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.48% 3%
CARA Cara Therapeutics, Inc. Buy 9.56% -6.12%
AGEN Agenus Inc. Buy 9.21% -9.51%
AADI Aadi Bioscience, Inc. Buy 10.62% 4.57%
PODD Insulet Corporation Buy 11.56% 5.05%
TVTX Travere Therapeutics, Inc. Buy 11.07% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 9.1% -3.01%
NVCR NovoCure Limited Buy 8.78% -6.48%
MYGN Myriad Genetics, Inc. Buy 8.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.46% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.5% -6.41%
AGEN Agenus Inc. Buy 9.27% -8.59%
AADI Aadi Bioscience, Inc. Buy 10.41% 2.86%
PODD Insulet Corporation Buy 11.6% 5.72%
TVTX Travere Therapeutics, Inc. Buy 9.98% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 9.07% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 9.35% 0%
NVCR NovoCure Limited Buy 9.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.61% -5.21%
ORGO Organogenesis Holdings Inc. Buy 9.67% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.52% -6.12%
AGEN Agenus Inc. Buy 8.99% -11.33%
AADI Aadi Bioscience, Inc. Buy 10.41% 2.86%
PODD Insulet Corporation Buy 11.4% 3.96%
TVTX Travere Therapeutics, Inc. Buy 10.1% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 9.59% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 11.35%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 9.76% -3.53%
CARA Cara Therapeutics, Inc. Buy 9.77% -3.5%
AGEN Agenus Inc. Buy 9.16% -9.51%
CERS Cerus Corporation Buy 9.29% -7.98%
AADI Aadi Bioscience, Inc. Buy 10.04% -0.57%
PODD Insulet Corporation Buy 11.07% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.81% -10.38%
TVTX Travere Therapeutics, Inc. Buy 9.62% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.42% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.34% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.13% 3.79%
AGEN Agenus Inc. Buy 9.11% -6.58%
CERS Cerus Corporation Buy 9.16% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.35% -4%
NEOG Neogen Corporation Buy 10.3% -2.15%
PODD Insulet Corporation Buy 10.55% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.55% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.33% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.49% -0.64%
ORGO Organogenesis Holdings Inc. Buy 9.93% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.01% 4.66%
AGEN Agenus Inc. Buy 9.84% 2.93%
CERS Cerus Corporation Buy 9.3% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.16% -4%
NEOG Neogen Corporation Buy 10.32% 0%
The percentage of cash held in the portfolio is: 22.63%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.75% 6.09%
ARDX Ardelyx, Inc. Buy 9.28% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.36% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.03% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.11% 7.87%
AGEN Agenus Inc. Buy 10.06% 7.31%
CERS Cerus Corporation Buy 9.35% 0%
AADI Aadi Bioscience, Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 20.7%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.05% -4.32%
ARDX Ardelyx, Inc. Buy 9.27% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.59% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.49% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.77% 0%
AGEN Agenus Inc. Buy 9.77% 0%
The percentage of cash held in the portfolio is: 41.07%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.08% -2.95%
ARDX Ardelyx, Inc. Buy 9.66% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.66% 0%
ORGO Organogenesis Holdings Inc. Buy 9.66% 0%
The percentage of cash held in the portfolio is: 59.94%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.22% -1.57%
The percentage of cash held in the portfolio is: 88.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.31% 7.37%
CYH Community Health Systems, Inc. Buy 10.88% -4.91%
The percentage of cash held in the portfolio is: 79.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 8.58% -3.03%
RCM R1 RCM Inc. Buy 9.46% 7.14%
CYH Community Health Systems, Inc. Buy 10.76% -7.66%
The percentage of cash held in the portfolio is: 71.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 8.72% -0.76%
RCM R1 RCM Inc. Buy 9.38% 7.06%
CYH Community Health Systems, Inc. Buy 10.96% -5.3%
RMD ResMed Inc. Buy 10.77% 3.67%
The percentage of cash held in the portfolio is: 60.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.94% -8.52%
OPK OPKO Health, Inc. Buy 8.87% 2.27%
RCM R1 RCM Inc. Buy 9.33% 7.83%
CYH Community Health Systems, Inc. Buy 11.2% -1.96%
RMD ResMed Inc. Buy 11.02% 7.5%
The percentage of cash held in the portfolio is: 51.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.88% -8.24%
OPK OPKO Health, Inc. Buy 8.98% 4.55%
RCM R1 RCM Inc. Buy 9.28% 8.44%
CYH Community Health Systems, Inc. Buy 11.13% -1.57%
HQY HealthEquity, Inc. Buy 10.87% -3.84%
HCSG Healthcare Services Group, Inc. Buy 9.19% -3.72%
RMD ResMed Inc. Buy 10.47% 3.13%
The percentage of cash held in the portfolio is: 32.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.53% 1.14%
OPK OPKO Health, Inc. Buy 9.08% 7.58%
RCM R1 RCM Inc. Buy 8.32% -1.15%
FATE Fate Therapeutics, Inc. Buy 8.16% -4.31%
CYH Community Health Systems, Inc. Buy 11.48% 3.34%
HQY HealthEquity, Inc. Buy 10.77% -3.09%
HCSG Healthcare Services Group, Inc. Buy 9.27% -1.12%
RMD ResMed Inc. Buy 10.22% 2.5%
The percentage of cash held in the portfolio is: 24.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 27.55%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 12.24% 26.42%
PDSB PDS Biotechnology Corporation Buy 8.38% -1.7%
OPK OPKO Health, Inc. Buy 9.23% 8.33%
RCM R1 RCM Inc. Buy 8.41% -1%
FATE Fate Therapeutics, Inc. Buy 7.93% -7.9%
CYH Community Health Systems, Inc. Buy 11.37% 1.38%
HQY HealthEquity, Inc. Buy 10.86% -3.16%
HCSG Healthcare Services Group, Inc. Buy 9.43% -0.43%
RMD ResMed Inc. Buy 10.07% 0%
The percentage of cash held in the portfolio is: 12.07%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 12.28% 30.89%
PDSB PDS Biotechnology Corporation Buy 8.97% 8.52%
OPK OPKO Health, Inc. Buy 8.95% 8.33%
RCM R1 RCM Inc. Buy 8.02% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.11% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 10.42% -4.26%
SMTI Sanara MedTech Inc. Buy 10.29% -5.45%
CYH Community Health Systems, Inc. Buy 11.07% 1.77%
HQY HealthEquity, Inc. Buy 10.7% -1.69%
HCSG Healthcare Services Group, Inc. Buy 9.18% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.63% 26.12%
PDSB PDS Biotechnology Corporation Buy 8.95% 10.23%
OPK OPKO Health, Inc. Buy 9.1% 12.12%
RCM R1 RCM Inc. Buy 8.08% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.01% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.32% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.86% 1.6%
SMTI Sanara MedTech Inc. Buy 10.69% 0%
CYH Community Health Systems, Inc. Buy 10.69% 0%
HQY HealthEquity, Inc. Buy 10.69% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • CYH
  • HQY
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.45% 23.69%
PDSB PDS Biotechnology Corporation Buy 9.12% 11.93%
OPK OPKO Health, Inc. Buy 8.77% 7.58%
RCM R1 RCM Inc. Buy 8.06% -0.84%
FATE Fate Therapeutics, Inc. Buy 7.99% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.66% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.74% 0%
The percentage of cash held in the portfolio is: 34.21%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.8% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 11.33% 19.76%
PDSB PDS Biotechnology Corporation Buy 8.91% 6.96%
OPK OPKO Health, Inc. Buy 8.96% 7.58%
RCM R1 RCM Inc. Buy 8.38% 0.92%
FATE Fate Therapeutics, Inc. Buy 7.83% -7%
PTGX Protagonist Therapeutics, Inc. Buy 9.95% 0%
The percentage of cash held in the portfolio is: 31.85%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
ACAD Sell All 16.37%
EGRX Sell All 20.09%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.92% 14.55%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.28% 28.79%
CYH Community Health Systems, Inc. Buy 11.77% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 10.99% 18.17%
PDSB PDS Biotechnology Corporation Buy 9.84% 20.17%
OPK OPKO Health, Inc. Buy 8.94% 9.09%
RCM R1 RCM Inc. Buy 8.42% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.28% 0%
The percentage of cash held in the portfolio is: 18.56%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.91% 11.78%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.79% 31.03%
CYH Community Health Systems, Inc. Buy 11.21% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 10.43% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.22% 9.94%
OPK OPKO Health, Inc. Buy 9.46% 12.88%
RCM R1 RCM Inc. Buy 8.52% 2%
The percentage of cash held in the portfolio is: 27.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.05% 13.35%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.54% 28.57%
CYH Community Health Systems, Inc. Buy 11.2% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 10.42% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.18% 9.66%
ALT Altimmune, Inc. Buy 7.33% -12.43%
OPK OPKO Health, Inc. Buy 9.64% 15.15%
RCM R1 RCM Inc. Buy 8.23% -1.46%
The percentage of cash held in the portfolio is: 20.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.92% 15.55%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.61% 33.48%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.41% 10.14%
CYH Community Health Systems, Inc. Buy 11.35% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 10.63% 15.37%
PDSB PDS Biotechnology Corporation Buy 9.25% 13.92%
ALT Altimmune, Inc. Buy 8.13% 0.13%
OPK OPKO Health, Inc. Buy 8.73% 7.58%
WST West Pharmaceutical Services, Inc. Buy 7.89% -1.88%
RCM R1 RCM Inc. Buy 8.09% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.77% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.04% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.67% 10.14%
CYH Community Health Systems, Inc. Buy 10.95% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 9.26% -1.97%
PDSB PDS Biotechnology Corporation Buy 9.17% 10.23%
BHVN Biohaven Ltd. Buy 8.73% 4.89%
ALT Altimmune, Inc. Buy 8.54% 2.67%
OPK OPKO Health, Inc. Buy 8.63% 3.79%
WST West Pharmaceutical Services, Inc. Buy 8.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.87% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.61% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.76% 6.55%
CYH Community Health Systems, Inc. Buy 10.27% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 9.14% -7.12%
PDSB PDS Biotechnology Corporation Buy 8.67% 0%
BHVN Biohaven Ltd. Buy 8.67% 0%
ALT Altimmune, Inc. Buy 8.67% 0%
OPK OPKO Health, Inc. Buy 8.67% 0%
The percentage of cash held in the portfolio is: 10.67%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.89% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.67% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.7% 6.02%
CYH Community Health Systems, Inc. Buy 10.21% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 9.2% -6.59%
The percentage of cash held in the portfolio is: 45.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.09% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.62% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.37% 0.9%
CYH Community Health Systems, Inc. Buy 10.55% 5.31%
NVRO Nevro Corp. Buy 9.76% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 9.3% -7.27%
The percentage of cash held in the portfolio is: 37.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.23% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.98% 16.74%
STAA STAAR Surgical Company Buy 10.8% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.55% 2.79%
CYH Community Health Systems, Inc. Buy 10.72% 7.19%
NVRO Nevro Corp. Buy 9.71% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 9.21% -7.95%
The percentage of cash held in the portfolio is: 26.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.71% 1.01%
MNKD MannKind Corporation Buy 9.01% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.86% 23.44%
STAA STAAR Surgical Company Buy 10.77% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.92% 3.19%
CYH Community Health Systems, Inc. Buy 9.72% 3.75%
ARDX Ardelyx, Inc. Buy 9.56% 2.16%
CHRS Coherus BioSciences, Inc. Buy 8.71% -6.94%
NVRO Nevro Corp. Buy 9.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
  • VRDN
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.72% 2.33%
MNKD MannKind Corporation Buy 9.14% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.88% 25%
STAA STAAR Surgical Company Buy 10.69% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.8% 3.14%
CYH Community Health Systems, Inc. Buy 9.73% 5%
ARDX Ardelyx, Inc. Buy 9.26% 0%
CHRS Coherus BioSciences, Inc. Buy 9.26% 0%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.96% 3.09%
MNKD MannKind Corporation Buy 9.41% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.82% 12.05%
STAA STAAR Surgical Company Buy 10.68% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.04% 3.94%
CYH Community Health Systems, Inc. Buy 9.42% 0%
The percentage of cash held in the portfolio is: 39.67%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings